Literature DB >> 2293509

Long-term follow-up of bone marrow transplant patients.

C J McGarigle1.   

Abstract

Preparation for discharge begins prior to the admission for bone marrow transplant. Assessment of the home environment and the effect of prolonged isolation on the life style of the patient and family are important factors. Once the transplant process has been accomplished and the patient meets the criteria for discharge, physical preparation of the home environment can begin. In the immediate post-transplant period, treatment or prophylaxis of graft-versus-host disease (GVHD) is monitored. Immune globulins may be replaced every three to four weeks. Long-term follow-up often continues for many years, especially when chronic GVHD is present. Continued psychosocial support is needed throughout this process to prepare the patient for re-entry into the community.

Entities:  

Mesh:

Year:  1990        PMID: 2293509      PMCID: PMC2589353     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  9 in total

Review 1.  Late complications of bone marrow transplant recipients: nursing care issues.

Authors:  J W Nims; S Strom
Journal:  Semin Oncol Nurs       Date:  1988-02       Impact factor: 2.315

2.  Gynecologic manifestations of chronic graft-versus-host disease.

Authors:  S L Corson; K Sullivan; F Batzer; C August; R Storb; E D Thomas
Journal:  Obstet Gynecol       Date:  1982-10       Impact factor: 7.661

3.  Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

Authors:  K M Sullivan; R P Witherspoon; R Storb; P Weiden; N Flournoy; S Dahlberg; H J Deeg; J E Sanders; K C Doney; F R Appelbaum
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

4.  Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.

Authors:  K M Sullivan; R P Witherspoon; R Storb; H J Deeg; S Dahlberg; J E Sanders; F R Appelbaum; K C Doney; P Weiden; C Anasetti
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

5.  Adaptation of adult bone marrow transplant recipient long-term survivors.

Authors:  D L Wolcott; D K Wellisch; F I Fawzy; J Landsverk
Journal:  Transplantation       Date:  1986-04       Impact factor: 4.939

6.  Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; G K Rivera; M J Schell; D Thornton; L Lott
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

7.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

8.  An analysis of factors predisposing to chronic graft-versus-host disease.

Authors:  O Ringdén; T Paulin; B Lönnqvist; B Nilsson
Journal:  Exp Hematol       Date:  1985-11       Impact factor: 3.084

9.  Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

Authors:  R Storb; R L Prentice; K M Sullivan; H M Shulman; H J Deeg; K C Doney; C D Buckner; R A Clift; R P Witherspoon; F A Appelbaum; J E Sanders; P S Stewart; E D Thomas
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.